Back to Search Start Over

Assessment of the application for renewal of authorisation of endo‐1,4‐β‐xylanase produced by Aspergillus nigerCBS 109.713 and endo‐1,4‐β‐glucanase produced by Aspergillus nigerDSM 18404 for poultry species, ornamental birds and weaned piglets, from BASF SE

Authors :
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
Vasileios Bampidis
Giovanna Azimonti
Maria de Lourdes Bastos
Henrik Christensen
Birgit Dusemund
Mojca Fašmon Durjava
Maryline Kouba
Marta López‐Alonso
Secundino López Puente
Francesca Marcon
Baltasar Mayo
Alena Pechová
Mariana Petkova
Fernando Ramos
Yolanda Sanz
Roberto Edoardo Villa
Ruud Woutersen
Pier Sandro Cocconcelli
Boet Glandorf
Lieve Herman
Miguel Prieto Maradona
Maria Saarela
Elisa Pettenati
Montserrat Anguita
Source :
EFSA Journal, Vol 18, Iss 12, Pp n/a-n/a (2020)
Publication Year :
2020
Publisher :
Wiley, 2020.

Abstract

Abstract Natugrain® TS/TS L is the trade name of the feed additive under assessment and contains endo‐1,4‐β‐xylanase and endo‐1,4‐β‐glucanase produced by genetically modified strains of Aspergillus niger. The product is currently authorised for use as a feed additive for poultry species, ornamental birds, weaned piglets and pigs for fattening. This scientific opinion concerns the renewal of the authorisation of this additive for poultry species, ornamental birds and weaned piglets. The applicant provided evidence that the additive in the market complies with the conditions of the authorisation. According to the information provided by the applicant, no new evidence has been identified that would make the FEEDAP Panel reconsider the previous conclusions regarding the safety for the target species, consumer, user and environment under the authorised conditions of use. The additive is safe for the target species for which the renewal of the authorisation is requested, the consumers and the environment. The additive is a potential skin and a respiratory sensitiser. The present application for renewal of the authorisation did not include a proposal for amending or supplementing the conditions of the original authorisation that would have an impact on the efficacy of the additive. Therefore, there was no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

Details

Language :
English
ISSN :
18314732
Volume :
18
Issue :
12
Database :
Directory of Open Access Journals
Journal :
EFSA Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.73cf7986d7fe4542a3a4fdbb63ac816c
Document Type :
article
Full Text :
https://doi.org/10.2903/j.efsa.2020.6331